Genetic ablation of Dpp4 in mice [24] improves insulin sensitivity and liver glucose metabolism, and DPP4 pharmacological inhibition reduces the development of hepatic steatosis and insulin resistance in mouse models of obesity and diabetes [25, 26]. The gene discussed is DPP4; the disease is obesity due to melanocortin 4 receptor deficiency.